Notice: Revision to the Guidance Document: Management of Drug Submissions and Applications

Health Canada is revising the Guidance Document entitled: The Management of Drug Submissions and Applications (MDSA). This document provides sponsors and Health Canada staff of the Therapeutic Products Directorate, the Biologic and Radiopharmaceutical Drugs Directorate, the Natural and Non-Prescription Health Products Directorate (Non-Prescription Drugs Evaluation Division), and the Marketed Health Products Directorate with operational direction and guidance regarding the way in which drug submissions, applications or post-market documents submitted to Health Canada are managed.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis : Révision à la Ligne directrice : Gestion des présentations et des demandes de drogue
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2021-07-07 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["révision des documents d'orientation", "présentations de médicaments", "demandes de médicaments", "présentations de documents post-commercialisation", "orientation opérationnelle"], "en": ["revising guidance document", "drug submissions", "drug applications", "post-market documents submissions", "operational direction"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source